Literature DB >> 17096712

Rotavirus outbreak in a remote Aboriginal community: the burden of disease.

Ben Gelbart1, Meredith Hansen-Knarhoi, Philippa Binns, Vicki Krause.   

Abstract

AIM: To document the burden of disease caused by an outbreak of rotavirus (RV) gastroenteritis in a remote Aboriginal community.
METHODS: During an outbreak of RV gastroenteritis, data were collected from patients notes, hospital and laboratory data. Age, date of presentation, severity of illness, number of total presentations, presentations per patient, total clinic hours per presentation, stool analysis, treatment and outcomes were measured. These data were compared with a time period of equal duration in order to establish a baseline burden of gastroenteritis.
RESULTS: In a remote Aboriginal community 26 patients were managed for acute diarrhoea between 19 September 2005 and 5 October 2005. Gastroenteritis was the diagnosis in 24 cases for which there were 55 presentations. Stool specimens were analysed in 14 (58%) cases. RV was identified in eight (57%) of these specimens. The majority (80%) had mild disease. Moderate disease was noted in 15% and 5% were follow-up reviews. There were no severe cases of gastroenteritis. Four patients required evacuation to hospital. From a total of 607 presentations to the clinic during this time period, 55 (9%) were managed for acute diarrhoea. In the comparative time period there were five (0.9%) cases of acute diarrhoea from a total of 571 presentations.
CONCLUSION: Rotavirus gastroenteritis places a large burden on remote Aboriginal communities and health-care centres in the form of morbidity, overworked clinic staff, economic cost and reduced capacity for primary health-care duties.

Entities:  

Mesh:

Year:  2006        PMID: 17096712     DOI: 10.1111/j.1440-1754.2006.00976.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  2 in total

1.  The ORVAC trial protocol: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis.

Authors:  Bianca Fleur Middleton; Mark A Jones; Claire S Waddington; Margaret Danchin; Carly McCallum; Sarah Gallagher; Amanda Jane Leach; Ross Andrews; Carl Kirkwood; Nigel Cunliffe; Jonathan Carapetis; Julie A Marsh; Tom Snelling
Journal:  BMJ Open       Date:  2019-11-14       Impact factor: 2.692

2.  The NICE-GUT trial protocol: a randomised, placebo controlled trial of oral nitazoxanide for the empiric treatment of acute gastroenteritis among Australian Aboriginal children.

Authors:  Claire S Waddington; Charlie McLeod; Peter Morris; Asha Bowen; Mark Naunton; Jonathan Carapetis; Keith Grimwood; Roy Robins-Browne; Carl D Kirkwood; Robert Baird; David Green; Ross Andrews; Deborah Fearon; Joshua Francis; Julie A Marsh; Thomas Snelling
Journal:  BMJ Open       Date:  2018-02-01       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.